09:51 AM EST - Cipher Pharmaceuticals Inc. : Announced that it has amended its distribution and supply agreement with Sun Pharmaceutical Industries, Inc. (previously Ranbaxy Laboratories Inc.) for Absorica®, an innovative formulation of the active ingredient isotretinoin, which is used in the treatment of severe acne. Cipher Pharmaceuticals Inc.
shares T.CPH are trading up $0.03 at $2.79.
